Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2013 | Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size | ZHONG-ZHE LIN ; Shau W.-Y.; CHIUN HSU ; YU-YUN SHAO ; Yeh Y.-C.; Kuo R.N.-C.; CHIH-HUNG HSU ; CHIH-HSIN YANG ; ANN-LII CHENG ; Lai M.-S. | PLoS ONE | 26 | 24 | |
2006 | Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent | Huang K.-M.; CHIH-HUNG HSU ; CHIA-HSIEN CHENG ; Lai M.-K.; Jeng S.-C.; Ting L.-L.; Huang W.-T. | Anticancer Research | 10 | 7 | |
2022 | Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2 | Finn, Richard S; Yau, Thomas; CHIH-HUNG HSU ; De Toni, Enrico N; Goyal, Lipika; Galle, Peter R; Qin, ShuKui; Rao, Sujata; Sun, Fangfang; Wang, Chunxiao; Widau, Ryan C; Zhu, Andrew X | The oncologist | 5 | 7 | |
2020 | Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer | Kojima T.; Shah M.A.; Muro K.; Francois E.; Adenis A.; CHIH-HUNG HSU ; Doi T.; Moriwaki T.; Kim S.-B.; Lee S.-H.; Bennouna J.; Kato K.; Shen L.; Enzinger P.; Qin S.-K.; Ferreira P.; Chen J.; Girotto G.; de la Fouchardiere C.; Senellart H.; Al-Rajabi R.; Lordick F.; Wang R.; Suryawanshi S.; Bhagia P.; Peter Kang S.; Metges J.-P.; KEYNOTE-181 Investigators | Journal of Clinical Oncology | 592 | 495 | |
2021 | Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites | GUO, JHE-CYUAN ; Lin, Chen Yuan; CHIA-CHI LIN ; TA-CHEN HUANG ; Lien, Ming Yu; LI-CHUN LU ; HUNG-YANG KUO ; CHIH-HUNG HSU | ONCOLOGY (United States) | 1 | 1 | |
2018 | Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma | Yang P.-C.; JHE-CYUAN GUO ; MIN-SHU HSIEH ; CHIA-CHI LIN ; CHIH-HUNG HSU | Journal of Thoracic Oncology | 6 | 4 | |
2011 | Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma | Feng-Ming Hsu ; JANG-MING LEE ; PEI-MING HUANG ; CHIA-CHI LIN ; CHIH-HUNG HSU ; YU-CHIEH TSAI ; Lee Y.-C.; CHIA-HSIEN CHENG | International Journal of Radiation Oncology Biology Physics | 38 | 36 | |
2017 | Right or left? Side selection for a totally implantable vascular access device: A randomised observational study | WEN-YING LIN ; CHIH-PENG LIN ; CHIH-HUNG HSU ; Lee, Ying Hui; Lin, Yi Ting; Hsu, Meng Chi; YU-YUN SHAO | British Journal of Cancer | 13 | 10 | |
2017 | A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement | YUN CHIANG ; CHIA-HSIEN CHENG ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Chia-Chi Lin ; CHIH-HUNG HSU ; ANN-LII CHENG ; YEONG-SHIAU PU | Journal of the Formosan Medical Association | 7 | 6 | |
2023 | Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma | BANG-BIN CHEN ; PO-CHIN LIANG ; TIFFANY TING-FANG SHIH ; TSUNG-HAO LIU ; YING-CHUN SHEN ; LI-CHUN LU ; ZHONG-ZHE LIN ; CHIUN HSU ; CHIH-HUNG HSU ; ANN-LII CHENG ; YU-YUN SHAO | European radiology | 17 | 13 | |
2021 | Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab | Zhu A.X.; Finn R.S.; Kang Y.-K.; Yen C.-J.; Galle P.R.; Llovet J.M.; Assenat E.; Brandi G.; Motomura K.; Ohno I.; Daniele B.; Vogel A.; Yamashita T.; CHIH-HUNG HSU ; Gerken G.; Bilbruck J.; Hsu Y.; Liang K.; Widau R.C.; Wang C.; Abada P.; Kudo M. | British Journal of Cancer | 37 | 35 | |
2012 | Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy | YU-YUN SHAO ; Huang C.-C.; Lin S.-D.; CHIH-HUNG HSU ; ANN-LII CHENG | Clinical Cancer Research | 39 | 37 | |
2015 | Serum transforming growth factor-β1 change after neoadjuvant chemoradiation therapy is associated with postoperative pulmonary complications in esophageal cancer patients undergoing combined modality therapy | SHAO-LUN LU ; Feng-Ming Hsu ; CHIAO-LING TSAI ; Wu J.-K.; JANG-MING LEE ; PEI-MING HUANG ; CHIH-HUNG HSU ; Koong A.C.; Chang D.T.; CHIA-HSIEN CHENG | International Journal of Radiation Oncology Biology Physics | 3 | 3 | |
2021 | Solving the deficit of cancer pain management skills by education programs | YU-YUN SHAO ; WEN-YING LIN ; CHIH-PENG LIN ; LI-CHUN LU ; CHIH-HUNG HSU | Supportive Care in Cancer | 2 | 2 | |
2015 | Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan | YU-YUN SHAO ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; ZHONG-ZHE LIN ; ANN-LII CHENG ; Lai M.-S. | Clinical Colorectal Cancer | 35 | 32 | |
2003 | Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma | ANN-LII CHENG ; Hsiung C.A.; Su I.-J.; PEI-JER CHEN ; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; CHIH-HUNG HSU ; HWEI-FANG TIEN ; Chao T.-Y.; Chen L.-T.; Whang-Peng J. | Hepatology | 264 | 226 | |
2018 | Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure | TSUNG-HAO LIU ; CHIH-HUNG HSU ; YU-YUN SHAO | Liver Cancer | 3 | 2 | |
2005 | Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment | CHIH-HSIN YANG ; Chen M.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Yu Y.-C.; Whang-Peng J.; PAN-CHYR YANG | Oncology | 5 | 4 | |
2004 | Synergistic antitumor activity of troxacitabine and camptothecin in selected human cancer cell lines | Kim T.E.; Park S.-Y.; CHIH-HUNG HSU ; Dutschman G.E.; Cheng Y.-C. | Molecular Pharmacology | 11 | 10 | |
2015 | Systematic review and network meta-analysis: Neoadjuvant chemoradiotherapy for locoregional esophageal cancer | Ta-Chen Huang ; CHIH-HUNG HSU ; CHIA-CHI LIN ; YU-KANG TU | Japanese Journal of Clinical Oncology | 30 | 27 | |